Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023)

Xenon Pharmaceuticals Inc., a neurology-focused biopharmaceutical company, announced it will provide updates on its neurology programs at the Annual Meeting of the American Epilepsy Society.